United Laboratories International Holdings Ltd (fra:UNJ) Share Price

Company Profile

Business description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
Contact
No. 6 Fuk Wang Street
Yuen Long Industrial Estate
New Territories
Hong Kong
HKG
T: +852 26871033
http://www.tul.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
17,000

Recommended

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.

Matthew Dolgin, CFA | 23 July 2025

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

John Abernethy | 23 July 2025

The offer price is well above our fair value.

Shaun Ler | 22 July 2025

Index	Last price	Change	% Change
All Ordinaries	9,000.00	1.40	-0.02%
CAC 40	7,850.43	106.02	1.37%
DAX 40	24,240.82	198.92	0.83%
Dow JONES (US)	45,010.29	507.85	1.14%
FTSE 100	9,061.49	37.68	0.42%
HKSE	25,538.07	408.04	1.62%
NASDAQ	21,020.02	127.33	0.61%
Nikkei 225	41,729.02	557.70	1.35%
NZX 50 Index	12,822.31	28.25	0.22%
S&P 500	6,358.91	49.29	0.78%
S&P/ASX 200	8,734.30	2.90	-0.03%
SSE Composite Index	3,582.30	0.44	0.01%